483 Valeant Canada LP Feb 2012

483 Valeant Canada LP Feb 2012

Robert Martin FDA$119.00 - Available Now

FDA investigators audited the Valeant Canada LP - Saint-Laurent, Canada facility and issued 3 inspectional observations (via FDA 483) on 14 Feb 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 14 Feb 2012
  • Location: Saint-Laurent, Canada
  • FEI: 3002807243
Add To Cart